Although angiogenic factors have been shown to be altered at the time of clinical disease, these factors are also altered well before the onset of clinical signs and symptoms.69, 70, 71,110,155 Elevated sFLT1 and depressed PlGF levels are more dramatically altered in preterm PE and in PE complicated by IUGR.110. This evidence concerns the gene PGF and fetal growth restriction.